Effect of infliximab combination therapy on inflammatory biomarkers and intestinal mucosal healing in patients with extensive Crohn&#x02019;s disease

Jian Jiafu; Liu Sixue; Wu Huibo; Zhong Wa; Xia Zhongsheng; Zhong Yingqiang

doi:10.3969/j.issn.0253-9802.2022.03.012

Effect of infliximab combination therapy on inflammatory biomarkers and intestinal mucosal healing in patients with extensive Crohn’s disease

Jian Jiafu, Liu Sixue, Wu Huibo, Zhong Wa, Xia Zhongsheng, Zhong Yingqiang

JOURNAL OF NEW MEDICINE ›› 2022, Vol. 53 ›› Issue (3) : 208-213.

PDF(1152 KB)

JOURNAL OF NEW MEDICINE ›› 2022, Vol. 53 ›› Issue (3) : 208-213. DOI: 10.3969/j.issn.0253-9802.2022.03.012

Original Research

Effect of infliximab combination therapy on inflammatory biomarkers and intestinal mucosal healing in patients with extensive Crohn’s disease

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 53(3): 208-213 https://doi.org/10.3969/j.issn.0253-9802.2022.03.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(1152 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2021-06-25	2022-03-15
Issue Date
2022-04-02

Please choose a citation manager

Content to export